Neuland Laboratories Ltd. (NEULANDLAB) Price & Analysis

Compare

3 Followers

NEULANDLAB Stock Chart & Stats

₹16866.65

₹591.15(4.14%)

At close: Jan 08 4:00 PM EST

₹16866.65

₹591.15(4.14%)

Day’s Range― - ―

52-Week Range₹10,060.00 - ₹19,748.40

Previous CloseN/A

Volume58.52K

Average Volume (3M)2.41K

Market Cap

₹225.89B

Enterprise Value₹152.85B

Total Cash (Recent Filing)₹2.40B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)128.2

Beta0.81

Next Earnings

Feb 16, 2026

EPS Estimate

85.1

Last Dividend Ex-Date

Jul 18, 2025

Dividend Yield0.07%

Share Statistics

EPS (TTM)75.50

Shares Outstanding12,829,889

10 Day Avg. Volume1,318

30 Day Avg. Volume2,408

Financial Highlights & Ratios

PEG Ratio-4.25

Price to Book (P/B)9.66

Price to Sales (P/S)9.98

P/FCF Ratio132.83

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

₹17,225.00

Price Target Upside2.12% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Neuland Laboratories Ltd. News

Neuland Laboratories Schedules Q2 FY26 Earnings Call

Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) just unveiled an update. Neuland Laboratories Limited has scheduled an earnings call...

1M ago

Neuland Laboratories Opens Special Window for Share Transfer Requests

Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) just unveiled an announcement. Neuland Laboratories Limited has announced a special window...

1M ago

Neuland Laboratories Announces Executive Restructuring via Postal Ballot

An announcement from Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) is now available. Neuland Laboratories Ltd. has announced a...

2M ago

Neuland Laboratories Issues Corrigendum to Postal Ballot Notice

Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) has issued an announcement. Neuland Laboratories Limited has announced a newspaper advertisement...

2M ago

Neuland Laboratories Opens Special Window for Physical Share Transfers

Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) has issued an announcement. Neuland Laboratories Ltd. has announced a special window...

3M ago

Neuland Laboratories Publishes Q1 2025 Financial Results

Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) has shared an announcement. Neuland Laboratories Limited has announced the publication of...

4M ago

NEULANDLAB FAQ

What was Neuland Laboratories Ltd.’s price range in the past 12 months?

Neuland Laboratories Ltd. lowest stock price was ₹10060.00 and its highest was ₹19748.40 in the past 12 months.

What is Neuland Laboratories Ltd.’s market cap?

Neuland Laboratories Ltd.’s market cap is ₹225.89B.

When is Neuland Laboratories Ltd.’s upcoming earnings report date?

Neuland Laboratories Ltd.’s upcoming earnings report date is Feb 16, 2026 which is in 80 days.

How were Neuland Laboratories Ltd.’s earnings last quarter?

Neuland Laboratories Ltd. released its earnings results on Nov 07, 2025. The company reported ₹75.5 earnings per share for the quarter, beating the consensus estimate of ₹54.92 by ₹20.58.

Is Neuland Laboratories Ltd. overvalued?

According to Wall Street analysts Neuland Laboratories Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Neuland Laboratories Ltd. pay dividends?

Neuland Laboratories Ltd. pays a Annually dividend of ₹12 which represents an annual dividend yield of 0.07%. See more information on Neuland Laboratories Ltd. dividends here

What is Neuland Laboratories Ltd.’s EPS estimate?

Neuland Laboratories Ltd.’s EPS estimate is 85.1.

How many shares outstanding does Neuland Laboratories Ltd. have?

Neuland Laboratories Ltd. has 12,829,889 shares outstanding.

What happened to Neuland Laboratories Ltd.’s price movement after its last earnings report?

Neuland Laboratories Ltd. reported an EPS of ₹75.5 in its last earnings report, beating expectations of ₹54.92. Following the earnings report the stock price went up 1.531%.

Which hedge fund is a major shareholder of Neuland Laboratories Ltd.?

Currently, no hedge funds are holding shares in IN:NEULANDLAB

Company Description

Neuland Laboratories Ltd.

Neuland Laboratories Ltd. (NEULANDLAB) is a prominent player in the pharmaceutical sector, primarily engaged in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates. The company operates in various therapeutic segments, including anti-infectives, cardiovascular, and central nervous system (CNS) drugs. Neuland Laboratories is known for its commitment to quality, innovation, and sustainability, providing high-quality products to global pharmaceutical companies and playing a critical role in the supply chain of essential medications.

Neuland Laboratories Ltd. (NEULANDLAB) Earnings & Revenues

Historic Earnings Reports

NEULANDLAB Stock 12 Month Forecast

Average Price Target

₹17,225.00

▲(2.12% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9364":"₹9,364","13295":"₹13,295","17226":"₹17,226","11329.5":"₹11,329.5","15260.5":"₹15,260.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹17K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹17K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹17K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9364,11329.5,13295,15260.5,17226],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Jan<br/>2025","9":"Jul<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16516.45,16570.953846153847,16625.457692307693,16679.96153846154,16734.465384615385,16788.96923076923,16843.473076923077,16897.976923076923,16952.48076923077,17006.984615384616,17061.48846153846,17115.992307692308,17170.496153846154,{"y":17225,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16516.45,16570.953846153847,16625.457692307693,16679.96153846154,16734.465384615385,16788.96923076923,16843.473076923077,16897.976923076923,16952.48076923077,17006.984615384616,17061.48846153846,17115.992307692308,17170.496153846154,{"y":17225,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16516.45,16570.953846153847,16625.457692307693,16679.96153846154,16734.465384615385,16788.96923076923,16843.473076923077,16897.976923076923,16952.48076923077,17006.984615384616,17061.48846153846,17115.992307692308,17170.496153846154,{"y":17225,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9365.34,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12493.05,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12520.58,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14609.65,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16647.36,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14297,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14297,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10608.36,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11464,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11864.77,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13041.9,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15387.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16516.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >